Concepedia

Author

João Lobo

Instituto Português de Oncologia Francisco GentilORCID

Also Known As

G. Fallara, J Lobo, J. Lobo, JOÃO LOBO, JOÃO PEDRO DE OLIVEIRA CAETANO LOBO, Joao Lobo, João Lobo, João P. Lobo, João Pedro de Oliveira Caetano Lobo, João Pedro de Oliveira Lobo

217

Publications

3.2K

Citations

32

H-Index

65

Concepts

All Affiliations

Instituto Português de Oncologia Francisco GentilUniversidade do PortoIPO PortoPrincess Máxima CenterErasmus MC Cancer Institute
JL

About

João Lobo is an author at Instituto Português de Oncologia Francisco Gentil specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

20

710

2

Engineering

3

3

81

3

Health Sciences

3

3

92

4

Natural Sciences

2

2

35

5

Anesthesia

2

2

79

João Lobo

×

56

Publications

1.9K

Citations

26

H-Index

YearCitations

Integrative epigenetic taxonomy of primary prostate cancer

Suzan Stelloo, Ekaterina Nevedomskaya, Yongsoo Kim,

Nature Communications

2018

154

Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data

João Lobo, Ad Gillis, Annette van den Berg,

Cells

2019

102

Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists

João Lobo, Ana Laura Costa, Bárbara Vilela-Salgueiro,

Human Pathology

2018

89

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer

Daniela Barros‐Silva, João Lobo, Catarina Guimarães‐Teixeira,

Cancers

2020

85

Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers

João Lobo, Ângelo Rodrigues, Rita de Cássia Avellaneda Guimarães,

Cancers

2019

69

m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance

João Lobo, Ana Laura Costa, Mariana Cantante,

Journal of Translational Medicine

2019

65

Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer

João Lobo, Ricardo Leão, Ad Gillis,

European Urology Oncology

2020

63

Germ cell tumour subtypes display differential expression of microRNA371a-3p

Bárbara Vilela-Salgueiro, Daniela Barros‐Silva, João Lobo,

Philosophical Transactions of the Royal Society B Biological Sciences

2018

59

JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma

Catarina Macedo‐Silva, Vera Miranda‐Gonçalves, Ana Lameirinhas,

Cell Death and Disease

2020

58

The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors

Vera Miranda‐Gonçalves, João Lobo, Catarina Guimarães‐Teixeira,

Journal of Experimental & Clinical Cancer Research

2021

54

Page 1